SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, has submitted the results of a 5-year efficacy and safety study of ArteFill® to the FDA in order to enhance product labeling. ArteFill® is the first and only non-resorbable injectable filler for the correction of wrinkles known as smile lines or nasolabial folds and was approved by the FDA in October 2006.
